NASH and cryptogenic cirrhosis: A histological analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Argo, 2009, Systematic review of risk factors for fibrosis progression in nonalcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019
Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114
Caldwell, 1999, Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease, Hepatology, 29, 664, 10.1002/hep.510290347
Maheshwari, 2006, Cryptogenic cirrhosis and NAFLD: Are they related?, Am J Gastroenterol, 101, 664, 10.1111/j.1572-0241.2006.00478.x
Poonawala, 2000, Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study, Hepatology, 32, 689, 10.1053/jhep.2000.17894
Browning, 2004, Ethnic differences in the prevalence of cryptogenic cirrhosis, Am J Gastroenterol, 99, 292, 10.1111/j.1572-0241.2004.04059.x
Heneghan, 2003, An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis., Liver Transpl, 9, 921, 10.1053/jlts.2003.50165
Contos, 2001, Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis, Liver Transpl, 7, 363, 10.1053/jlts.2001.23011
Ayata, 2002, Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation, Hum Pathol, 33, 1098, 10.1053/hupa.2002.129419
Berg, 2002, Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): A long-term documentation before and after OLT, Transplantation, 74, 792, 10.1097/00007890-200209270-00010
Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701
Adams, 2005, The natural history of nonalcoholic fatty liver disease: A population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014
Ekstedt, 2006, Long-term follow-up of patients with NAFLD and elevated liver enzymes, Hepatology, 44, 865, 10.1002/hep.21327
Lee, 1989, Nonalcoholic steatohepatitis: A study of 49 patients, Hum Pathol, 20, 594, 10.1016/0046-8177(89)90249-9
Argo, 2009, Thiazolidinediones in NASH: Sustained benefit after drug discontinuation?, J Clin Gastroenterol, 43, 565, 10.1097/MCG.0b013e31818f4fc2
Abdelmalek, 1995, Two cases from the spectrum of nonalcoholic steatohepatitis, J Clin Gastroenterol, 20, 127, 10.1097/00004836-199503000-00011
Bacon, 1994, Nonalcoholic steatohepatitis: An expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6
Ratziu, 2000, Liver fibrosis in overweight patients, Gastroenterology, 118, 1117, 10.1016/S0016-5085(00)70364-7
Hui, 2005, Histological progression of non-alcoholic fatty liver disease in chinese patients, Aliment Pharmacol Ther, 21, 407, 10.1111/j.1365-2036.2005.02334.x
Matsui, 1995, Focal sparing of segment IV in fatty livers shown by sonography and CT: Correlation with aberrant gastric venous drainage, AJR Am J Roentgenol, 164, 1137, 10.2214/ajr.164.5.7717220
Seifalian, 1999, The effect of graded steatosis on flow in the hepatic parenchymal microcirculation, Transplantation, 68, 780, 10.1097/00007890-199909270-00009
Nosadini, 1984, Carbohydrate and lipid metabolism in cirrhosis. evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow, J Clin Endocrinol Metab, 58, 1125, 10.1210/jcem-58-6-1125
Roskams, 2003, Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease., Am J Pathol, 163, 1301, 10.1016/S0002-9440(10)63489-X
Yeh, 2007, Pathology of nonalcoholic fatty liver disease, Am J Clin Path, 128, 837, 10.1309/RTPM1PY6YGBL2G2R